» Articles » PMID: 23460055

Neisseria Gonorrhoeae Antimicrobial Resistance Among Men Who Have Sex with Men and Men Who Have Sex Exclusively with Women: the Gonococcal Isolate Surveillance Project, 2005-2010

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 2013 Mar 6
PMID 23460055
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Gonorrhea treatment has been complicated by antimicrobial resistance in Neisseria gonorrhoeae. Gonococcal fluoroquinolone resistance emerged more rapidly among men who have sex with men (MSM) than men who have sex exclusively with women (MSW).

Objective: To determine whether N. gonorrhoeae urethral isolates from MSM were more likely than isolates from MSW to exhibit resistance to or elevated minimum inhibitory concentrations (MICs) of antimicrobials used to treat gonorrhea.

Design: 6 years of surveillance data from the Gonococcal Isolate Surveillance Project.

Setting: Publicly funded sexually transmitted disease clinics in 30 U.S. cities.

Patients: Men with a total of 34 600 episodes of symptomatic urethral gonorrhea.

Measurements: Percentage of isolates exhibiting resistance or elevated MICs and adjusted odds ratios for resistance or elevated MICs among isolates from MSM compared with isolates from MSW.

Results: In all U.S. regions except the West, isolates from MSM were significantly more likely to exhibit elevated MICs of ceftriaxone and azithromycin than isolates from MSW (P < 0.050). Isolates from MSM had a high prevalence of resistance to ciprofloxacin, penicillin, and tetracycline and were significantly more likely to exhibit antimicrobial resistance than isolates from MSW (P < 0.001).

Limitations: Sentinel surveillance may not be representative of all patients with gonorrhea. HIV status, travel history, and antimicrobial use data were missing for some patients.

Conclusion: Men who have sex with men are vulnerable to the emerging threat of antimicrobial-resistant N. gonorrhoeae. Because antimicrobial susceptibility testing is not routinely done in clinical practice, clinicians should monitor for treatment failures among MSM diagnosed with gonorrhea. Strengthened prevention strategies for MSM and new antimicrobial treatment options are needed.

Citing Articles

Association between city-level sociodemographic and health factors and the prevalence of antimicrobial-resistant gonorrhea in the US, 2000-2019: a spatial-temporal modeling study.

Li J, Murray-Watson R, St Cyr S, Grad Y, Warren J, Yaesoubi R Lancet Reg Health Am. 2025; 43:101006.

PMID: 39968293 PMC: 11834109. DOI: 10.1016/j.lana.2025.101006.


Neisseria gonorrhoeae treatment failure to the recommended antibiotic regimen-Québec, Canada, 2015-19.

Blouin K, Lefebvre B, Trudelle A, Defay F, Perrault-Sullivan G, Gnimatin J J Antimicrob Chemother. 2024; 79(11):3029-3040.

PMID: 39288011 PMC: 11531823. DOI: 10.1093/jac/dkae327.


Personalizing the empiric treatment of gonorrhea using machine learning models.

Murray-Watson R, Grad Y, St Cyr S, Yaesoubi R PLOS Digit Health. 2024; 3(8):e0000549.

PMID: 39141668 PMC: 11324139. DOI: 10.1371/journal.pdig.0000549.


Risk Compensation After Initiation of Daily Oral Pre-exposure Prophylaxis Among Sexual and Gender Minorities in Nigeria.

Adeyemi O, Nowak R, Morgan D, Sam-Agudu N, Craddock J, Zhan M Arch Sex Behav. 2024; 53(7):2807-2816.

PMID: 38684621 PMC: 11758484. DOI: 10.1007/s10508-024-02859-9.


Navigating the network: a narrative overview of AMR surveillance and data flow in the United States.

Robillard D, Sundermann A, Raux B, Prinzi A Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e55.

PMID: 38655022 PMC: 11036423. DOI: 10.1017/ash.2024.64.


References
1.
Spellberg B, Powers J, Brass E, Miller L, Edwards Jr J . Trends in antimicrobial drug development: implications for the future. Clin Infect Dis. 2004; 38(9):1279-86. DOI: 10.1086/420937. View

2.
Knapp J, Ohye R, Neal S, Parekh M, Higa H, Rice R . Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii. Antimicrob Agents Chemother. 1994; 38(9):2200-3. PMC: 284712. DOI: 10.1128/AAC.38.9.2200. View

3.
Morse S, Lysko P, McFarland L, Knapp J, Sandstrom E, Critchlow C . Gonococcal strains from homosexual men have outer membranes with reduced permeability to hydrophobic molecules. Infect Immun. 1982; 37(2):432-8. PMC: 347552. DOI: 10.1128/iai.37.2.432-438.1982. View

4.
Warner L, Stone K, Macaluso M, Buehler J, Austin H . Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis. 2005; 33(1):36-51. DOI: 10.1097/01.olq.0000187908.42622.fd. View

5.
Ison C, Hussey J, Sankar K, Evans J, Alexander S . Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill. 2011; 16(14). View